Works matching IS 18696953 AND DT 2024 AND VI 15 AND IP 8
Results: 12
Evaluation of Cardiovascular Risk in People with Type 1 Diabetes: A Comprehensive and Specific Proposed Practical Approach.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1831, doi. 10.1007/s13300-024-01616-4
- By:
- Publication type:
- Article
Risk of Urogenital Bacterial Infection with Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study Using a Claims Database.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1821, doi. 10.1007/s13300-024-01613-7
- By:
- Publication type:
- Article
Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1687, doi. 10.1007/s13300-024-01612-8
- By:
- Publication type:
- Article
Impact of Initial Treatment Policies on Long-term Complications and Costs in Japanese Patients with Type 2 Diabetes: A Real-World Database Study.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1811, doi. 10.1007/s13300-024-01611-9
- By:
- Publication type:
- Article
Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1673, doi. 10.1007/s13300-024-01610-w
- By:
- Publication type:
- Article
Triglyceride Glucose Index for the Detection of Diabetic Kidney Disease and Diabetic Peripheral Neuropathy in Hospitalized Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1799, doi. 10.1007/s13300-024-01609-3
- By:
- Publication type:
- Article
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1769, doi. 10.1007/s13300-024-01608-4
- By:
- Publication type:
- Article
Perspective of Continuous Glucose Monitoring-Based Interventions at the Various Stages of Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1657, doi. 10.1007/s13300-024-01607-5
- By:
- Publication type:
- Article
Frequency and Severity of Hypoglycemia Under Conditions of Increased Hypoglycemic Risk with Insulin Efsitora Alfa Versus Insulin Glargine Treatment in Participants with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1785, doi. 10.1007/s13300-024-01605-7
- By:
- Publication type:
- Article
Perspectives and Behaviors of People with Diabetes toward Time in Range and Glucose Control in Diabetes Management: An Online Survey.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1735, doi. 10.1007/s13300-024-01603-9
- By:
- Publication type:
- Article
Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1717, doi. 10.1007/s13300-024-01594-7
- By:
- Publication type:
- Article
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 8, p. 1749, doi. 10.1007/s13300-024-01588-5
- By:
- Publication type:
- Article